hotspot -WSS

hotspot

author：leisure time 2025-09-27 16:23:09 - browse：7

Adobe

Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack.

The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding. Medicare will advance up to 30 days of payment, based on the average monthly amount a provider received from Medicare from August 1 to October 31, 2023. The providers are expected to repay the money 90 days after receiving the payment, with interest beginning to accrue 30 days after that.

“We welcome today’s announcement and will continue to work with policymakers as the impacts from the cyberattack persist,” the American Hospital Association said in a statement after the announcement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Congressmen charge Covid hearing ‘could have been an email’

WSS

CDC's new outbreak response network to include Northeastern

General Catalyst, Summa Health deal will turn on physician buy

Commercial surrogacy can be ethical, despite pope’s claims

Vertigo drug brings hope for rare neuron disorder, Niemann

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Apple Vision Pro: A first look at health apps on the new VR headset

focus

hotspot

knowledge

Heart attack and stroke risk calculators need revising

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Anesthesiologist group: stop taking Ozempic before surgery

Medical student insurance fails on mental health care coverage

Malaria cases in Florida and Texas: Here’s what you need to know

SAMSHA loosens regulations on methadone treatment centers

Wildfire smoke exposes gaps in outdoor worker protections

Ukraine and a new approach to mental health in war

The cancer drug shortage isn’t new — and neither are the solutions

FDA panel to weigh approval of NurOwn, controversial ALS drug

explore

Commercial surrogacy can be ethical, despite pope’s claims

Vertigo drug brings hope for rare neuron disorder, Niemann

Cognito secures funding to test medical device for Alzheimer's

A $475,000 price tag for a new cancer drug: crazy or meh?

Drug for rare kidney disease narrowly misses mark in clinical trial

Apple Vision Pro: A first look at health apps on the new VR headset

hotspot

focus

Wikipedia

hotspot